The Cancer Institute of New Jersey CINJ Rutgers — New Brunswick, New Jersey

The Cancer Institute of New Jersey CINJ Rutgers is a clinical research site located in New Brunswick, New Jersey, United States 08901.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

The Cancer Institute of New Jersey CINJ Rutgers has participated in 1 clinical trials.

Therapeutic areas: Prostate Cancer Metastatic.

Sponsors: Hookipa Biotech GmbH.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Cancer Institute of New Jersey CINJ Rutgers?

The Cancer Institute of New Jersey CINJ Rutgers has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Cancer Institute of New Jersey CINJ Rutgers conducted?

The Cancer Institute of New Jersey CINJ Rutgers has 1 clinical trials on record. Their work covers Prostate Cancer Metastatic.

Is The Cancer Institute of New Jersey CINJ Rutgers accredited by Crixeo Health?

The Cancer Institute of New Jersey CINJ Rutgers has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Cancer Institute of New Jersey CINJ Rutgers?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.